Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the history, and the older v3.6.0 entry was removed. This reflects an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-27T03:25:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.0 was added and the study is flagged as no longer looking for participants, indicating recruitment has closed. The previous revision reference v3.5.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-06-12T23:36:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The history shows a new revision entry, v3.5.5, replacing the previous v3.5.4. This indicates a minor update to the study record history metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-05T20:20:40.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, was added to the record history, and the prior revision, v3.5.3, was removed from the list.
    Difference
    0.1%
    Check dated 2026-05-15T09:42:30.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page’s UI/documentation footer revision number was updated from v3.5.2 to v3.5.3, indicating a minor system or display update rather than a change to the clinical trial record itself.
    Difference
    0.0%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the version history.
    Difference
    0.0%
    Check dated 2026-04-17T02:16:17.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.